Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expanded Access to StrataGraft for Deep Partial-Thickness Thermal Burns
NCT04123548Phase 3Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Feb 2020
- Primary completion
- Jan 2022
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen in Thermal Burn, sponsored by Mallinckrodt Pharmaceuticals. Started Feb 2020; status: completed.
02
Drugs
allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen
03
Conditions
Thermal Burn
Beyond the preview
Go deeper on NCT04123548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04123548.